Venous thromboembolism in children: Rivaroxaban effective and safe even with extended use: Study Dr. Kamal Kant Kohli30 May 2025 8:45 PM ISTVenous thromboembolism (VTE) is a life-threatening complication in children with serious underlying conditions such as heart defects or cancer....
Hydroxychloroquine Shows No Significant Benefit for Hand Function in Systemic Sclerosis: Study Medha Baranwal30 May 2025 8:45 PM ISTItaly: Recent data published in Arthritis Research & Therapy indicate that hydroxychloroquine (HCQ) does not significantly improve functional...
Tirzepatide Demonstrates Consistent Efficacy in OSA Across All Severity Levels, suggests research Jacinthlyn Sylvia30 May 2025 8:30 PM ISTA recent post-hoc analysis of the SURMOUNT-OSA trials revealed that tirzepatide significantly improves obstructive sleep apnea (OSA) symptoms and...
Alembic Pharma bags USFDA okay for blood cancer drug Bosutinib Ruchika Sharma30 May 2025 2:52 PM ISTVadodara: Alembic Pharmaceuticals Limited has announced that the company has received final approval from the US Food & Drug Administration...
Biannual Injection of zilebesiran Shows Promising Blood Pressure Control In clinical trial: JAMA Prem Aggarwal30 May 2025 9:00 AM ISTResults from a clinical trial led by researchers from Queen Mary University of London, published today in JAMA, show that giving people with high...
Semaglutide Reduces Risk of Osteoporosis and Gout in Obese Type 2 Diabetes Patients: Study Dr Riya Dave30 May 2025 9:00 AM ISTResearchers have found in a new cohort study that semaglutide offers significant protection against osteoporosis and gout in individuals with obesity...
Study Reveals How Your Daily Rhythm Affects Aging and Wellness Dr. Bhumika Maikhuri30 May 2025 8:00 AM ISTA new study published in Medicine & Science in Sports and Exercise reveals that the timing and consistency of daily activity may significantly...
Rare Case of Hemorrhagic Shock After Dental Extraction Highlights Risks in Patients on Dual Antithrombotic Therapy Medha Baranwal29 May 2025 9:00 PM ISTFrance: A recent case report published in the International Journal of Surgery Case Reports has brought attention to a rare but serious complication...
AstraZeneca Imfinzi recommended for approval in EU for adults with muscle-invasive bladder cancer Ruchika Sharma29 May 2025 2:15 PM ISTCambridge: AstraZeneca has announced that Imfinzi (durvalumab) has been recommended for approval in the European Union (EU) for the...
Bayer Sevabertinib gets USFDA Priority Review status for HER2-mutant non-small cell lung cancer Ruchika Sharma29 May 2025 11:15 AM ISTBerlin: Bayer has received Priority Review status from the US Food and Drug Administration (FDA) for the investigational compound sevabertinib...
Bristol Myers Squibb bags European Commission nod for Subcutaneous formulation of Opdivo across multiple solid tumor indications Ruchika Sharma29 May 2025 10:00 AM ISTPrinceton: Bristol Myers Squibb has received approval from the European Commission (EC) for a new Opdivo (nivolumab) formulation...
Regardless of Drug Used, Weight Gain Worsens Type 2 Diabetes Outcomes: GRADE Study Medha Baranwal29 May 2025 9:00 AM ISTUSA: A recent study published in Diabetes Care has found that weight gain among individuals with type 2 diabetes is significantly associated with...
